Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.

Identifieur interne : 000074 ( Main/Corpus ); précédent : 000073; suivant : 000075

Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.

Auteurs : Yao Chen ; Mei-Xiu Li ; Guo-Dong Lu ; Han-Ming Shen ; Jing Zhou

Source :

RBID : pubmed:33907517

English descriptors

Abstract

The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. One major challenge in the battle against this deadly disease is to find effective therapy. Due to the availability and proven clinical record of hydroxychloroquine (HCQ) and chloroquine (CQ) in various human diseases, there have been enormous efforts in repurposing these two drugs as therapeutics for COVID-19. To date, substantial amount of work at cellular, animal models and clinical trials have been performed to verify their therapeutic potential against COVID-19. However, neither lab-based studies nor clinical trials have provided consistent and convincing evidence to support the therapeutic value of HCQ/CQ in the treatment of COVID-19. In this mini review we provide a systematic summary on this important topic and aim to reveal some truth covered by the mystery regarding the therapeutic value of HCQ/CQ in COVID-19.

DOI: 10.7150/ijbs.59547
PubMed: 33907517
PubMed Central: PMC8071775

Links to Exploration step

pubmed:33907517

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.</title>
<author>
<name sortKey="Chen, Yao" sort="Chen, Yao" uniqKey="Chen Y" first="Yao" last="Chen">Yao Chen</name>
<affiliation>
<nlm:affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Li, Mei Xiu" sort="Li, Mei Xiu" uniqKey="Li M" first="Mei-Xiu" last="Li">Mei-Xiu Li</name>
<affiliation>
<nlm:affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lu, Guo Dong" sort="Lu, Guo Dong" uniqKey="Lu G" first="Guo-Dong" last="Lu">Guo-Dong Lu</name>
<affiliation>
<nlm:affiliation>Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shen, Han Ming" sort="Shen, Han Ming" uniqKey="Shen H" first="Han-Ming" last="Shen">Han-Ming Shen</name>
<affiliation>
<nlm:affiliation>Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Jing" sort="Zhou, Jing" uniqKey="Zhou J" first="Jing" last="Zhou">Jing Zhou</name>
<affiliation>
<nlm:affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33907517</idno>
<idno type="pmid">33907517</idno>
<idno type="doi">10.7150/ijbs.59547</idno>
<idno type="pmc">PMC8071775</idno>
<idno type="wicri:Area/Main/Corpus">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000074</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.</title>
<author>
<name sortKey="Chen, Yao" sort="Chen, Yao" uniqKey="Chen Y" first="Yao" last="Chen">Yao Chen</name>
<affiliation>
<nlm:affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Li, Mei Xiu" sort="Li, Mei Xiu" uniqKey="Li M" first="Mei-Xiu" last="Li">Mei-Xiu Li</name>
<affiliation>
<nlm:affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lu, Guo Dong" sort="Lu, Guo Dong" uniqKey="Lu G" first="Guo-Dong" last="Lu">Guo-Dong Lu</name>
<affiliation>
<nlm:affiliation>Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shen, Han Ming" sort="Shen, Han Ming" uniqKey="Shen H" first="Han-Ming" last="Shen">Han-Ming Shen</name>
<affiliation>
<nlm:affiliation>Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Jing" sort="Zhou, Jing" uniqKey="Zhou J" first="Jing" last="Zhou">Jing Zhou</name>
<affiliation>
<nlm:affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of biological sciences</title>
<idno type="eISSN">1449-2288</idno>
<imprint>
<date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (virology)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Disease Models, Animal (MeSH)</term>
<term>Endocytosis (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>SARS-CoV-2 (isolation & purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>COVID-19</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Disease Models, Animal</term>
<term>Endocytosis</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. One major challenge in the battle against this deadly disease is to find effective therapy. Due to the availability and proven clinical record of hydroxychloroquine (HCQ) and chloroquine (CQ) in various human diseases, there have been enormous efforts in repurposing these two drugs as therapeutics for COVID-19. To date, substantial amount of work at cellular, animal models and clinical trials have been performed to verify their therapeutic potential against COVID-19. However, neither lab-based studies nor clinical trials have provided consistent and convincing evidence to support the therapeutic value of HCQ/CQ in the treatment of COVID-19. In this mini review we provide a systematic summary on this important topic and aim to reveal some truth covered by the mystery regarding the therapeutic value of HCQ/CQ in COVID-19.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">33907517</PMID>
<DateCompleted>
<Year>2021</Year>
<Month>05</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>05</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1449-2288</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2021</Year>
</PubDate>
</JournalIssue>
<Title>International journal of biological sciences</Title>
<ISOAbbreviation>Int J Biol Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.</ArticleTitle>
<Pagination>
<MedlinePgn>1538-1546</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7150/ijbs.59547</ELocationID>
<Abstract>
<AbstractText>The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. One major challenge in the battle against this deadly disease is to find effective therapy. Due to the availability and proven clinical record of hydroxychloroquine (HCQ) and chloroquine (CQ) in various human diseases, there have been enormous efforts in repurposing these two drugs as therapeutics for COVID-19. To date, substantial amount of work at cellular, animal models and clinical trials have been performed to verify their therapeutic potential against COVID-19. However, neither lab-based studies nor clinical trials have provided consistent and convincing evidence to support the therapeutic value of HCQ/CQ in the treatment of COVID-19. In this mini review we provide a systematic summary on this important topic and aim to reveal some truth covered by the mystery regarding the therapeutic value of HCQ/CQ in COVID-19.</AbstractText>
<CopyrightInformation>© The author(s).</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Yao</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Mei-Xiu</ForeName>
<Initials>MX</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Guo-Dong</ForeName>
<Initials>GD</Initials>
<AffiliationInfo>
<Affiliation>Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Han-Ming</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>04</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Australia</Country>
<MedlineTA>Int J Biol Sci</MedlineTA>
<NlmUniqueID>101235568</NlmUniqueID>
<ISSNLinking>1449-2288</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004705" MajorTopicYN="N">Endocytosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">CQ</Keyword>
<Keyword MajorTopicYN="Y">HCQ</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="Y">clinical trials</Keyword>
<Keyword MajorTopicYN="Y">therapy</Keyword>
</KeywordList>
<CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2021</Year>
<Month>02</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2021</Year>
<Month>03</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>19</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>4</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33907517</ArticleId>
<ArticleId IdType="doi">10.7150/ijbs.59547</ArticleId>
<ArticleId IdType="pii">ijbsv17p1538</ArticleId>
<ArticleId IdType="pmc">PMC8071775</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Front Med (Lausanne). 2020 Jul 31;7:480</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32850922</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2020 Sep;26(9):1276-1277</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32422406</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Heart Rhythm. 2020 Sep;17(9):1425-1433</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32407884</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jun;55(6):105969</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32278811</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33515285</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Trop Med Hyg. 1963 Mar;12:121-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14021822</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26955-26965</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33037151</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Pharmacol. 2020 Nov 12;11:569665</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33364944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Malar J. 2011 May 24;10:144</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21609473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Trop Med Hyg. 2020 Oct;103(4):1635-1639</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32828135</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Infect Dis. 2021 Jan;102:538-543</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33181328</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Intern Med. 2020 Nov;35(11):3308-3314</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32885373</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 May 14;181(4):914-921.e10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biol Sci. 2020 Mar 15;16(10):1724-1731</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32226290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Med. 2021 Dec;53(1):117-134</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33095083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2007 Nov-Dec;3(6):581-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17700057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2016 May;15(5):327-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26868298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virulence. 2020 Dec;11(1):805-810</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32567972</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>mBio. 2020 May 22;11(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32444382</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ecancermedicalscience. 2017 Nov 23;11:781</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29225688</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Rheumatol. 2020 Nov;2(11):e698-e711</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32864627</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Cell Biol. 2014 Aug;24(8):449-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24746011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2020 Mar;16(3):155-166</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32034323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Travel Med Infect Dis. 2020 May - Jun;35:101735</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32387694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 1993 Feb-Mar;57(2-3):203-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8361993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 2014 Feb;39(2):61-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24369758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Med Virol. 2021 Mar;31(2):e2163</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32969125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21221847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2004 Jul;73(3):332-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15170625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Jun 23;323(24):2493-2502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32392282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Pract. 2020 Nov;74(11):e13600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32603531</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 16;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32674126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Pharm Ther. 2021 Feb;46(1):17-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32981089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Cell Biol. 2020 May 18;12(4):322-325</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32236562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Pharmacol. 2020 Aug;177(15):3361-3362</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32602956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Cell Biol. 2003 Aug;15(4):414-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med (N Y). 2020 Dec 18;1(1):114-127.e3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32838355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Postgrad Med. 2020 Sep;132(7):604-613</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32496926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ophthalmology. 2016 Jun;123(6):1386-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26992838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Public Health. 2020 May 29;8:252</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32574312</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2021 Jan;27(1):19-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32860962</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Turk J Med Sci. 2020 Apr 15;50(SI-1):611-619</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32293834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Emerg Med. 2020 Oct;38(10):2209-2217</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33071096</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2020 Dec;16(12):2267-2270</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32521191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Drug Investig. 2018 Aug;38(8):653-671</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29737455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Med Virol. 2018 Jul;28(4):e1973</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29709097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24841269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>HIV AIDS (Auckl). 2015 Apr 08;7:95-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25897264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Sep;585(7826):584-587</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32698191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Sep;585(7826):588-590</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32698190</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2018 Jun;51(6):918-924</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29501821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Infect Dis. 2021 Mar;104:34-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33359949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2020 Dec 2;15(12):e0242763</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33264337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Cell. 2021 Feb 22;56(4):427-442.e5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33422265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2018 May 17;10(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29772762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jun;55(6):105988</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32305587</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci China Life Sci. 2020 Oct;63(10):1515-1521</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32418114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Cardiol. 2020 Sep 1;5(9):1036-1041</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32936252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 1999 Feb;42(2):357-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10025931</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Aug 7;369(6504):718-724</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32661059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2006 Feb;6(2):67-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16439323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Reprod Immunol. 2020 Jun;139:103122</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32244166</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 2017 Mar;44(3):398</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28250164</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000074 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000074 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33907517
   |texte=   Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33907517" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021